Literature DB >> 21302341

"Replicated" genome wide association for dependence on illegal substances: genomic regions identified by overlapping clusters of nominally positive SNPs.

Tomas Drgon1, Catherine A Johnson, Michelle Nino, Jana Drgonova, Donna M Walther, George R Uhl.   

Abstract

Declaring "replication" from results of genome wide association (GWA) studies is straightforward when major gene effects provide genome-wide significance for association of the same allele of the same SNP in each of multiple independent samples. However, such unambiguous replication may be unlikely when phenotypes display polygenic genetic architecture, allelic heterogeneity, locus heterogeneity, and when different samples display linkage disequilibria with different fine structures. We seek chromosomal regions that are tagged by clustered SNPs that display nominally significant association in each of several independent samples. This approach provides one "nontemplate" approach to identifying overall replication of groups of GWA results in the face of difficult genetic architectures. We apply this strategy to 1 million (1M) SNP Affymetrix and Illumina GWA results for dependence on illegal substances. This approach provides high confidence in rejecting the null hypothesis that chance alone accounts for the extent to which clustered, nominally significant SNPs from samples of the same racial/ethnic background identify the same chromosomal regions. There is more modest confidence in: (a) identification of individual chromosomal regions and genes and (b) overlap between results from samples of different racial/ethnic backgrounds. The strong overlap identified among the samples with similar racial/ethnic backgrounds, together with prior work that identified overlapping results in samples of different racial/ethnic backgrounds, support contributions to individual differences in vulnerability to addictions that come from both relatively older allelic variants that are common in many current human populations and newer allelic variants that are common in fewer current human populations.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21302341      PMCID: PMC3282182          DOI: 10.1002/ajmg.b.31143

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  30 in total

1.  Multivariate assessment of factors influencing illicit substance use in twins from female-female pairs.

Authors:  L M Karkowski; C A Prescott; K S Kendler
Journal:  Am J Med Genet       Date:  2000-10-09

2.  Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers.

Authors:  S S Smith; B F O'Hara; A M Persico; D A Gorelick; D B Newlin; D Vlahov; L Solomon; R Pickens; G R Uhl
Journal:  Arch Gen Psychiatry       Date:  1992-09

3.  Power and sample size calculations. A review and computer program.

Authors:  W D Dupont; W D Plummer
Journal:  Control Clin Trials       Date:  1990-04

4.  D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers.

Authors:  A M Persico; G Bird; F H Gabbay; G R Uhl
Journal:  Biol Psychiatry       Date:  1996-10-15       Impact factor: 13.382

Review 5.  Genetic dissection of complex traits.

Authors:  E S Lander; N J Schork
Journal:  Science       Date:  1994-09-30       Impact factor: 47.728

6.  Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins.

Authors:  K S Kendler; L M Karkowski; M C Neale; C A Prescott
Journal:  Arch Gen Psychiatry       Date:  2000-03

7.  Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms.

Authors:  G R Uhl; Q R Liu; D Walther; J Hess; D Naiman
Journal:  Am J Hum Genet       Date:  2001-11-06       Impact factor: 11.025

8.  Genome-wide association study of alcohol dependence.

Authors:  Jens Treutlein; Sven Cichon; Monika Ridinger; Norbert Wodarz; Michael Soyka; Peter Zill; Wolfgang Maier; Rainald Moessner; Wolfgang Gaebel; Norbert Dahmen; Christoph Fehr; Norbert Scherbaum; Michael Steffens; Kerstin U Ludwig; Josef Frank; H Erich Wichmann; Stefan Schreiber; Nico Dragano; Wolfgang H Sommer; Fernando Leonardi-Essmann; Anbarasu Lourdusamy; Peter Gebicke-Haerter; Thomas F Wienker; Patrick F Sullivan; Markus M Nöthen; Falk Kiefer; Rainer Spanagel; Karl Mann; Marcella Rietschel
Journal:  Arch Gen Psychiatry       Date:  2009-07

9.  Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities.

Authors:  M T Tsuang; M J Lyons; J M Meyer; T Doyle; S A Eisen; J Goldberg; W True; N Lin; R Toomey; L Eaves
Journal:  Arch Gen Psychiatry       Date:  1998-11

10.  Genome wide association for addiction: replicated results and comparisons of two analytic approaches.

Authors:  Tomas Drgon; Ping-Wu Zhang; Catherine Johnson; Donna Walther; Judith Hess; Michelle Nino; George R Uhl
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more
  22 in total

1.  Characterization of DSM-IV Opioid Dependence Among Individuals of European Ancestry.

Authors:  Leslie A Brick; Lauren Micalizzi; Valerie S Knopik; Rohan H C Palmer
Journal:  J Stud Alcohol Drugs       Date:  2019-05       Impact factor: 2.582

2.  Mouse Model for Protein Tyrosine Phosphatase D (PTPRD) Associations with Restless Leg Syndrome or Willis-Ekbom Disease and Addiction: Reduced Expression Alters Locomotion, Sleep Behaviors and Cocaine-Conditioned Place Preference.

Authors:  Jana Drgonova; Donna Walther; Katherine J Wang; G Luke Hartstein; Bryson Lochte; Juan Troncoso; Noriko Uetani; Yoichiro Iwakura; George R Uhl
Journal:  Mol Med       Date:  2015-07-14       Impact factor: 6.354

3.  Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults.

Authors:  Adam M Leventhal; Matthew G Kirkpatrick; Mollie S Pester; John E McGeary; Robert M Swift; Steve Sussman; Christopher W Kahler
Journal:  Psychopharmacology (Berl)       Date:  2016-10-22       Impact factor: 4.530

Review 4.  Human cell adhesion molecules: annotated functional subtypes and overrepresentation of addiction-associated genes.

Authors:  Xiaoming Zhong; Jana Drgonova; Chuan-Yun Li; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2015-05-18       Impact factor: 5.691

5.  Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence.

Authors:  Lingjun Zuo; Fengyu Zhang; Heping Zhang; Xiang-Yang Zhang; Fei Wang; Chiang-Shan R Li; Lingeng Lu; Jiang Hong; Lin Lu; John Krystal; Hong-Wen Deng; Xingguang Luo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-04-04       Impact factor: 3.568

Review 6.  PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.

Authors:  George R Uhl; Maria J Martinez
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

7.  Cadherin 13: human cis-regulation and selectively-altered addiction phenotypes and cerebral cortical dopamine in knockout mice.

Authors:  Jana Drgonova; Donna Walther; G Luke Hartstein; Mohammad O Bukhari; Michael H Baumann; Jonathan Katz; Frank Scott Hall; Elizabeth R Arnold; Shaun Flax; Anthony Riley; Olga Rivero-Martin; Klaus-Peter Lesch; Juan Troncoso; Barbara Ranscht; George R Uhl
Journal:  Mol Med       Date:  2016-08-18       Impact factor: 6.354

Review 8.  Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?

Authors:  F Scott Hall; Jana Drgonova; Siddharth Jain; George R Uhl
Journal:  Pharmacol Ther       Date:  2013-07-18       Impact factor: 12.310

9.  Cocaine reward is reduced by decreased expression of receptor-type protein tyrosine phosphatase D (PTPRD) and by a novel PTPRD antagonist.

Authors:  George R Uhl; Maria J Martinez; Paul Paik; Agnieszka Sulima; Guo-Hua Bi; Malliga R Iyer; Eliot Gardner; Kenner C Rice; Zheng-Xiong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

10.  Case-control association study of WLS variants in opioid and cocaine addicted populations.

Authors:  Richard C Crist; Lisa M Ambrose-Lanci; Angela Zeng; Cindy Yuan; Kyle M Kampman; Helen M Pettinati; David W Oslin; Charles P O'Brien; Thomas N Ferraro; Glenn A Doyle; Falk W Lohoff; Wade H Berrettini
Journal:  Psychiatry Res       Date:  2013-04-05       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.